Gene	Mutation	ProtMut	MutReads	WTReads	VAF	Info
ASXL1	chr20:32366465-32367727_Del:AGA	S47_Del:R	3	72	0.040	Neutral
ASXL1	chr20:32436180-32436180_Ins:A	N1158fs*5	3	67	0.043	Sequencing_artefact
CBL	chr11:119274894-119274894_Ins:T	L272fs*3	5	55	0.083	Sequencing_artefact
CEBPA	chr19:33302102-33302104_Del:CGC	D104_Del:G	3	80	0.036	Neutral
CSF3R	chr1:36467309-36467311_Del:CTG	R653-K654_Del:NR	51	504	0.092	Neutral
CSF3R	chr1:36472277-36472277_Sub:C>T	D320N	338	361	0.484	Neutral
ETV6	chr12:11650159-11752450_Del:AGC	E12_Del:Q	4	92	0.042	Neutral
EZH2	chr7:148828812-148828812_Sub:C>G	D185H	12	10	0.545	Neutral
FLT3	chr13:28018505-28018505_Sub:C>G	D835H	35	229	0.133	Oncogenic
FLT3	chr13:28018505-28018505_Sub:C>A	D835Y	17	229	0.069	Oncogenic
FLT3	chr13:28023477-28028287_ITD	E762-D763_Ins:EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFHRTWTEIFKEHNFSFYPTFQSHPNSSMPGSREVQIHPDSDQISGLHGNSFHSE	14	244	0.054	Oncogenic
FLT3	chr13:28048320-28048320_Ins:GGGAGA	R386-K387_Ins:ER	7	278	0.025	Neutral
FLT3	chr13:28050157-28050157_Sub:G>A	T227M	146	131	0.527	Neutral
FLT3	chr13:28100491-28100491_Sub:T>C	D7G	73	89	0.451	Neutral
GATA2	chr3:128486108-128486108_Sub:C>T	A164T	29	66	0.305	Neutral
GNAS	chr20:58898985-58898985_Ins:GCA	G728-E729_Ins:S	25	128	0.163	Neutral
IDH1	chr2:208243593-208243593_Sub:C>T	V178I	87	57	0.604	Neutral
IDH1	chr2:208251539-208251539_Ins:T	I5fs*12	8	193	0.040	Sequencing_artefact
JAK2	chr9:5069060-5069060_Ins:A	N457fs*1	3	63	0.045	Sequencing_artefact
KIT	chr4:54699764-54699764_Ins:CAG	Q251-T252_Ins:Q	29	343	0.078	Neutral
KIT	chr4:54727298-54727298_Sub:A>C	M541L	100	81	0.552	Neutral
KIT	chr4:54729384-54729384_Ins:T	L682fs*5	6	223	0.026	Sequencing_artefact
KIT	chr4:54729485-54731329_Del:GCA	D715_Del:S	77	163	0.321	Neutral
KMT2A	chr11:118471919-118471919_Ins:A	I256fs*1	4	31	0.114	Sequencing_artefact
KMT2A	chr11:118472296-118472296_Ins:A	A383fs*5	5	20	0.200	Sequencing_artefact
KMT2A	chr11:118491308-118491316_Del:AGGTACAGA	T1604-D1606_Del:GTE	21	12	0.636	Neutral
KMT2A	chr11:118505200-118505200_Ins:A	I3105fs*7	6	13	0.316	Sequencing_artefact
NPM1	chr5:171392817-171392817_Ins:A	V156fs*5	101	2488	0.039	Sequencing_artefact
NPM1	chr5:171392914-171392914_Ins:A	V156fs*5	134	2527	0.050	Sequencing_artefact
NRAS	chr1:114708595-114708595_Ins:T	K170fs*5	14	165	0.078	Sequencing_artefact
PHF6	chrX:134393951-134393951_Ins:AGC	A139-D140_Ins:A	7	29	0.194	Neutral
PML-RARA	PML-RARA_chr15-chr17_PE	PE	10	162_57	NA	Oncogenic
PML-RARA	PML:chr15:74023408-RARA:chr17:40348316	PML.K394-RARA.I61	5	36-4	NA	Oncogenic
RUNX1	chr21:34880647-34880648_Sub:AG>CC	N139K	6	70	0.079	Neutral
SF3B1	chr2:197401451-197401451_Ins:A	F815fs*1	80	369	0.178	Sequencing_artefact
SF3B1	chr2:197416765-197416765_Ins:T	K214fs*20	28	342	0.076	Sequencing_artefact
STAG2	chrX:124025890-124025890_Sub:G>A	G32E	10	180	0.053	Neutral
STAG2	chrX:124030967-124030967_Ins:A	G46fs*40	12	162	0.069	Sequencing_artefact
STAG2	chrX:124081476-124081476_Sub:A>G	T958A	3	144	0.020	Neutral
STAG2	chrX:124086710-124086710_Ins:A	S1075fs*11	9	223	0.039	Sequencing_artefact
TET2	chr4:105235006-105235006_Sub:G>A	G355D	50	71	0.413	Neutral
TET2	chr4:105272693-105272693_Ins:A	R1440fs*37	7	72	0.089	Sequencing_artefact
TET2	chr4:105275794-105275794_Sub:A>G	I1762V	56	33	0.629	Neutral
TET2	chr4:105276349-105276349_Ins:A	V1949fs*6	10	66	0.132	Sequencing_artefact
TP53	chr17:7676154-7676154_Sub:G>C	P72R	81	0	1.000	Neutral
WT1	chr11:32389178-32391978_Del:ACTTGTTTT	T476-E478_Del:KTS	9	12	0.429	Neutral
WT1	chr11:32396367-32396370_Del:CGTA	V379fs*68	8	3	0.727	Oncogenic